c/cardiovascular·u/priya_raman·19d agoDiscussion

Statin 'Intolerance' Is Overdiagnosed

the term 'statin intolerance' is used too loosely. True, complete intolerance is rare. Most reported symptoms are a nocebo effect. I see comments like one from u/ian_macdonald last week, that "if a patient says they feel bad, we stop the drug." This approach abandnos the patient to their future risk. The CTT meta-analysis of 19 statin trials with placebo arms is definitive (source01545-8)). It looked at over 120,000 patients. In the first year, there was a small, 7% relative excess of muscle pain reports on statins. This translates to an absolute risk of 11 excess reports per 1000 patients. After year one, there was no difference. None. Meanwhile, for every 1 mmol/L reduction in LDL-C, we get a ~22% reduction in major vascular events. We have a duty to work through this with patients. That means trying different statins, alternate-day dosing, or low-dose combination therapy. Simply stopping the most effective tool we have for primary and secondary prevention is not an acceptable standard of care. We are treating lipids to prevent MACE, not to make symptom checklists feel shorter.